Eli Lilly and Co (NYSE:LLY)
| 237.88 Delayed Data As of Jan 26 |  -1.58 / -0.66%Today’s Change | 178.58 Today|||52-Week Range 283.90 | -13.88% Year-to-Date |
Latest LLY News | Press Releases
Today’s Trading
| Previous close | 239.46 |
| Today’s open | 239.50 |
| Day’s range | 235.90 - 242.43 |
| Volume | 2,913,234 |
| Average volume (3 months) | 2,970,796 |
| Market cap | $232.5B |
Data as of 4:00pm ET, 01/26/2022
Growth & Valuation
| Earnings growth (last year) | +36.99% |
| Earnings growth (this year) | +2.24% |
| Earnings growth (next 5 years) | +17.13% |
| Revenue growth (last year) | +9.95% |
| P/E ratio | 36.3 |
| Price/Sales | 6.28 |
| Price/Book | 41.21 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie | +0.72 | +0.54% |
| MRKMerck | -0.46 | -0.58% |
| NVSNovartis | -0.27 | -0.32% |
| AZNAstraZeneca | -0.72 | -1.24% |
Data as of 4:37pm ET, 01/26/2022
Financials
| Next reporting date | February 3, 2022 |
| EPS forecast (this quarter) | $2.45 |
| Annual revenue (last year) | $24.5B |
| Annual profit (last year) | $6.2B |
| Net profit margin | 25.24% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |
Forecasts
